Marker Therapeutics Inc (MRKR)

[microcapbiotech]

I think that you are absolutely correct, and that is what has been happening.
But we (TPIV/MRKR) are not alone. There are a number of biotech stocks that "someones" are playing around with, all stocks with small float, low volume, no great major interest, up and down, and up and down, in that trading range that's just big enough so they can pay their trade associated fees and taxes, and still have enough left over for a worthwhile profit.

They KNOW that there are three kinds of basic players in their game.
US, who are either too small or too inactive traders to be able to influence their game.
INSIDERS/VENTURE/INSTITUTIONAL/FUNDS, that are generally "longer" term holders, who therefore will not be actively disrupting their game.
THEM, who know that they are the only active players of any major consequence, so if they work together, each taking their majority profit in turn, they control the game.

UNTIL WE GET:
A Much Larger float available.
Great results from a MRKR MultiTAA T Cell Therapy trial, so that the Marker aspect is given much more regard as opposed to the TPIV side of the merger.

If we get both of those things, we should get a ton more interest, a lot more major buyers and funds buying, and we should finally be able to kick the manipulators and short sellers out of here.

I HOPE

P.S. That's why in an earlier post I said a one billion dollar market cap … around the second quarter of 2020.